Global Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research

Global Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research

Global Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research

Salud

According to a new report Global Pharmacogenomics Market, published by KBV research, The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.



The Hospitals and Clinics market dominated the Global Pharmacogenomics Market by End User in 2018, growing at a CAGR of 8.5 % during the forecast period. The Research Institutions market is expected to witness highest CAGR of 9.1% during (2019-2025).



The North America market dominated the Global Infectious Diseases Market by Region in 2018, growing at a CAGR of 9.1 % during the forecast period. The Europe market is expected to witness a CAGR of 9.3% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 11.2% during (2019-2025).



The Sequencing market in the Global Pharmacogenomics Market by Technology would grow at a CAGR of 8 % during the forecast period. The Polymerase Chain Reaction market is expected to witness a CAGR of 8.1% during (2019-2025).



Full Report: https://www.kbvresearch.com/pharmacogenomics-market 



The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.



Global Pharmacogenomics Market Segmentation



By Technology



Sequencing



Polymerase Chain Reaction



Electrophoresis



Mass Spectrometry



Microarray



Others



By Application



Oncology



Psychiatry



Infectious Diseases



Neurological Diseases



Pain management



Cardiovascular Diseases



Others



By End User



Hospitals and Clinics



Research Institutions



Academic Institutes



By Geography



North America



US



Canada



Mexico



Rest of North America



Europe



Germany



UK



France



Russia



Spain



Italy



Rest of Europe



Asia Pacific



China



Japan



India



South Korea



Singapore



Malaysia



Rest of Asia Pacific



LAMEA



Brazil



Argentina



UAE



Saudi Arabia



South Africa



Nigeria



Rest of LAMEA



Companies Profiled



Abbott Laboratories



Empire Genomics LLC



Illumina, Inc.



Oneome LLC



Myriad Genetics Inc.



Thermo Fisher Scientific, Inc.



Teva Pharmaceuticals Industries Ltd.



Bayer AG



Opko Health, Inc.



Becton, Dickinson and Company



Unique Offerings from KBV Research



Exhaustive coverage



Highest number of market tables and figures



Subscription based model available



Guaranteed best price



Assured post sales research support with 10% customization free



Pharmacogenomics Market Related Reports:



North America Market



Europe Market



Asia Pacific Market



LAMEA Market



 

KBV ResearchGlobal Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research
posicionamiento en buscadores